What is Regencell Bioscience Holdings Ltd (RGC) stock price today?

Regencell Bioscience Holdings Ltd (RGC) currently trades at $28.95 per share. The stock has a market capitalization of $14.32B and a P/E ratio of —x.

Is RGC stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Regencell Bioscience Holdings Ltd has a Smart Value Score of 20/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is —.

Is Regencell Bioscience Holdings Ltd financially healthy?

Regencell Bioscience Holdings Ltd's Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of — places it in the —.

RGC

Regencell Bioscience Holdings Ltd

NASDAQ: RGC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$28.95

-0.34% today

Updated 2026-04-29

Market cap

$14.32B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.01

Dividend yield

—

52W range

$2 – $84

Volume

0.1M

Market cap

$14.32B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.01

Dividend yield

—

52W range

$2 – $84

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

7.3

Quality

B+

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$—

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.11x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Thin margins at 0.00%

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	—	—
Net income	$-7.42M	$-5.87M	$-4.30M	$-3.58M	$-1.73M
EPS	—	—	—	—	$-0.01
Free cash flow	$-6.05M	$-4.99M	$-4.01M	$-3.27M	—
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
RGC	$14.32B	20	4.3	3.0	5.0	7.3	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Regencell Bioscience Holdings Ltd trades at $28.95. Our Smart Value Score of 20/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score.

Frequently asked questions

What is Regencell Bioscience Holdings Ltd's stock price?

Regencell Bioscience Holdings Ltd (RGC) trades at $28.95.

Is Regencell Bioscience Holdings Ltd overvalued?

Smart Value Score 20/100 (Grade F, Strong Sell).

What is the price target of Regencell Bioscience Holdings Ltd (RGC)?

The analyst target price is $—, representing NaN% downside from the current price of $28.95.

Piotroski F-Score?

2/9 — weak financial health.

Company info

SectorHEALTHCARE

IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.regencellbioscience.com

Quick metrics

P/S ratio—

ROE-54.80%

Beta2.25

50D MA$27.20

200D MA$20.62

Shares out0.49B

Float0.04B

Short ratio—

Avg volume0.1M

Performance

1 week+2.26%

1 month+13.84%

3 months+3.78%

YTD+37.86%

1 year—

3 years—

5 years—

Compare

RGC vs LLY →RGC vs JNJ →RGC vs ABBV →Stock screener →